Las Vegas, Nevada (January 5, 2006) Business Wire

On December 14, 2005, The Board of Directors of Nutri Pharmaceuticals Research, Inc (NPRI) took action to implement a reverse split of our issued and outstanding common stock on a one for twelve (1:12) basis (the Reverse Split).

The Company's Board of Directors approved these actions on December 14, 2005 and recommended the implementation of the reverse split of the company's issued and outstanding common shares. The Reverse Split occurred on December 31, 2005, (the "Effective Date")

The National Association of Securities Dealers issued a new trading symbol, which is NRPR. Our common stock is quoted on the National Quotation Bureau's "Pinksheets" system.

Nutri Pharmaceuticals Research, Inc. is an 11-year-old company with average revenue of $1.5 Million per annum over the last five years. . NPRI has a patented new powdering process called O2P™. This exciting new technology allows NPRI to produce powders from oils, pastes and liquids from materials that could not be converted into powder in the past. As an added feature, the powder process does not use heat, cold or pressure as do older techniques such as spray- and freeze-drying.